<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03026816</url>
  </required_header>
  <id_info>
    <org_study_id>NEUROSURG-2017-25478</org_study_id>
    <nct_id>NCT03026816</nct_id>
  </id_info>
  <brief_title>Epidural Stimulation After Neurologic Damage</brief_title>
  <acronym>E-STAND</acronym>
  <official_title>Epidural Stimulation for Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Minnesota Office of Higher Education</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Minneapolis Veterans Affairs Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hennepin Healthcare Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hennepin County Medical Center, Minneapolis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate a method to optimize parameter settings in epidural spinal cord&#xD;
      stimulation used to recover lower extremity volitional movement. The study will also&#xD;
      characterize improvement in autonomic function (such as blood pressure control) and other&#xD;
      functions related to spinal cord injury.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidural spinal cord stimulation for the purpose of facilitating volitional movement is a new&#xD;
      and novel neuromodulatory treatment. Epidural SCS has a long history of use for chronic pain&#xD;
      with established medical device platforms. The purpose of this study is to investigate and&#xD;
      establish the use of SCS for volitional movement. Specifically, establishing the&#xD;
      disinhibitory effect of SCS in a greater population with inherent greater variability.&#xD;
&#xD;
      In addition to establishing the disinhibitory effect of SCS for cSCI, our study attempts to&#xD;
      explore the parameter space of the spinal cord stimulator platforms in order to optimize&#xD;
      stimulation settings for patients through the creation of a clinical decision support system&#xD;
      (CDSS). Preliminary evidence suggests benefit to autonomic function, and this study also&#xD;
      begins to explore the effects of SCS on cardiovascular function, urinary function,&#xD;
      psychiatric outcomes, and quality of life, which all offer significant potential for patients&#xD;
      suffering from chronic spinal cord injury.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 7, 2017</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All subjects will receive study intervention. Outcome assessments will be tested while the stimulator unit is on (intervention) and off (sham) during the study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Masking is done during formal testing of BMCA</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Volitional Response Index Magnitude</measure>
    <time_frame>Months: 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15</time_frame>
    <description>Brain Motor Control Assessment Volitional Response Index Magnitude</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Blood pressure (Systolic and Diastolic)</measure>
    <time_frame>Over 12 months</time_frame>
    <description>Blood pressure measured during epidural stimulation (continuous)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebrovascular Assessment Change</measure>
    <time_frame>Months: 3, 6, 9</time_frame>
    <description>cerebral blood flow (CBF) during tilt table</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Visual Neurocognitive Assessment</measure>
    <time_frame>Months: 3, 6, 9</time_frame>
    <description>Stroop Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accelerometer investigation of Parameter Space</measure>
    <time_frame>Evaluated 1 hour of 4 days per week over 12 months</time_frame>
    <description>wireless home accelerometer volitional movement detection system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of SCS on urinary control</measure>
    <time_frame>Months: 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15</time_frame>
    <description>subjective measures of urinary control</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Paraplegia, Complete</condition>
  <arm_group>
    <arm_group_label>Epidural Spinal Cord Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural Spinal Cord Stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural Spinal Cord Stimulation</intervention_name>
    <description>epidural spinal cord stimulator</description>
    <arm_group_label>Epidural Spinal Cord Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  22 years of age or older&#xD;
&#xD;
          -  Able to undergo the informed consent/assent process&#xD;
&#xD;
          -  Stable, motor-complete paraplegia&#xD;
&#xD;
          -  Discrete spinal cord injury between C6 and T10&#xD;
&#xD;
          -  ASIA A or B Spinal Cord Injury Classification&#xD;
&#xD;
          -  Medically stable in the judgement of the principal investigator&#xD;
&#xD;
          -  Intact segmental reflexes below the lesion of injury&#xD;
&#xD;
          -  Greater than 1 year since initial injury and at least 6 months from any required&#xD;
             spinal instrumentation&#xD;
&#xD;
          -  Willing to attend all scheduled appointments&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diseases and conditions that would increase the morbidity and mortality of spinal cord&#xD;
             injury surgery (e.g. cardiopulmonary issues)&#xD;
&#xD;
          -  Inability to withhold antiplatelet/anticoagulation agents perioperatively&#xD;
&#xD;
          -  Significant dysautonomia that would prohibit rehabilitation or assisted standing or&#xD;
             any history of CVA or MI associated with autonomic dysreflexia. A single tilt table&#xD;
             test with syncope, presyncope, or SBP &lt; 50 or &gt;200.&#xD;
&#xD;
          -  Other conditions that would make the subject unable to participate in&#xD;
             testing/rehabilitation in the judgement of the principal investigator&#xD;
&#xD;
          -  Current and anticipated need for opioid pain medications or pain that would prevent&#xD;
             full participation in the rehabilitation program in the judgement of the principal&#xD;
             investigator&#xD;
&#xD;
          -  Clinically significant mental illness in the judgement of the principal investigator&#xD;
&#xD;
          -  Botulinum toxin injections in the previous 6 months&#xD;
&#xD;
          -  Volitional movements present during EMG testing in bilateral lower extremities&#xD;
&#xD;
          -  Unhealed spinal fracture&#xD;
&#xD;
          -  Presence of significant contracture&#xD;
&#xD;
          -  Presence of pressure ulcers&#xD;
&#xD;
          -  Recurrent urinary tract infection refractory to antibiotics&#xD;
&#xD;
          -  Current Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Darrow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Study Coordinator</last_name>
    <phone>612-873-9113</phone>
    <email>estand@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Darrow, MD MPH</last_name>
    <phone>612-217-4290</phone>
    <email>estand@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Darrow, MD MPH</last_name>
      <phone>612-217-4290</phone>
      <email>estand@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Study Coordinator</last_name>
      <phone>612-873-9113</phone>
      <email>estand@umn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Darrow, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uzma Samadani, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.estand.org</url>
    <description>Clinical Trial Website</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 1, 2017</study_first_submitted>
  <study_first_submitted_qc>January 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2017</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epidural stimulation</keyword>
  <keyword>spinal cord stimulation</keyword>
  <keyword>autonomic dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Paraplegia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

